BDX 241220 220.00P (BDX241220P220000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

BDX241220P220000

Watchlist

0.40
+0.10+33.33%

15min DelayClose Dec 13 16:00 ET

1.20High0.40Low

Intraday

5D
Daily

News

Weekly Buzz: Tech stocks hit high scores on ominous day
Kevin Travers16:29 ET
(BDX) - Analyzing Becton Dickinson's Short Interest
Benzinga15:00 ET
Market Mixed on Friday the 13th | Livestock
Kevin TraversDec 13 10:46 ET
JPMorgan Adjusts Becton, Dickinson and Company Price Target to $245 From $250, Maintains Neutral Rating
MT NewswiresDec 13 08:19 ET · Ratings
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $265
Moomoo NewsDec 13 05:31 ET · Ratings
Thursday Ends in Index Declines | Wall Street Today
Kevin TraversDec 12 16:29 ET

Comments

103208831

Apr 18 11:43

$Becton Dickinson & Co (BDX.US)$ GAME OVER stock.

Moomoo AI

Feb 29 06:14

Despite a dip in earnings, Becton Dickinson's high P/E ratio persists due to anticipated robust future growth, outpacing the broader market. Investors' confidence in the company's future earnings is high, indicating the share price is unlikely to drop significantly soon.

Earnings Tell The Story For Becton, Dickinson and Company (NYSE:BDX)

Alvinnnnnnngenius

Dec 7, 2023 05:54

Big news

$Becton Dickinson & Co (BDX.US)$ BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Moomoo AI

Nov 21, 2023 05:52

Dr. Silverman's extensive experience and zeal for innovation, evidence generation, clinical development, medical safety, and compliance is predicted to boost BD's innovation pipeline and foster improved, personalized care.

Press Release: BD Names Dr. Ronald Silverman as Chief Medical Officer

Moomoo AI

Oct 10, 2023 11:30

Market sentiment towards Becton, Dickinson and Company shows no major shift in the past year. However, the rise in total shareholder return hints at a growing positivity.

Investing in Becton Dickinson (NYSE:BDX) a Year Ago Would Have Delivered You a 15% Gain